A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide

Details for Australian Patent Application No. 2001243941 (hide)

Owner Macfarlane Burnet Institute for Medical Research and Public Health Limited

Inventors Li, Fan; Anderson, David Andrew; Purcell, Damian Francis John

Agent Davies Collison Cave

Pub. Number AU-B-2001243941

PCT Pub. Number WO01/73078

Priority PQ6616 31.03.00 AU

Filing date 30 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 28 September 2006

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

Event Publications

28 September 2006 Application Accepted

  Published as AU-B-2001243941

25 January 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001243942-Insulin potentiating peptides

2001243940